Cargando…

1410. Isoniazid Therapy for Latent Tuberculosis Infection in Patients with Cancer Treated with Checkpoint Inhibitors Immunotherapy

BACKGROUND: Data on the efficacy and tolerability of latent tuberculosis infection (LTBI) treatment in cancer patients receiving checkpoint inhibitor immunotherapy (CPI) is limited. We sought to assess LTBI therapy and its adverse events and outcomes in patients treated with CPI. METHODS: We perform...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malek, Alexandre, Chaftari, Patrick, Okhuysen, Pablo C, Dagher, Hiba, Torres, Harrys A, Hachem, Ray Y, Chaftari, Anne-Marie, Viola, George, Kontoyiannis, Dimitrios P, Mulanovich, Victor E, Raad, Issam I
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644907/ http://dx.doi.org/10.1093/ofid/ofab466.1602

Ejemplares similares

1636. Risk of Latent Tuberculosis Reactivation in Patients Treated with Checkpoint Inhibitors Immunotherapy Compared to Other Anti-Cancer Therapies including Hematopoietic Cell Transplantation
por: Malek, Alexandre, et al.
Publicado: (2020)

1769. The Impact of Checkpoint Inhibitor Immunotherapy on Infections in Lung Cancer Patients
por: Malek, Alexandre, et al.
Publicado: (2019)

Procalcitonin for antimicrobial stewardship among cancer patients admitted with COVID-19
por: Dagher, Hiba, et al.
Publicado: (2022)

The role of procalcitonin in identifying high‐risk cancer patients with febrile neutropenia: A useful alternative to the multinational association for supportive care in cancer score
por: Chaftari, Patrick, et al.
Publicado: (2021)

357. A Comparison of Chest CT Findings in Cancer and Non-Cancer Patients with COVID-19
por: Malek, Alexandre, et al.
Publicado: (2021)

1228. The Role of Procalcitonin (PCT) and Lactic Acid in Febrile Neutropenic Cancer Patients in an Oncological Emergency Center
por: Chaftari, Patrick, et al.
Publicado: (2020)

356. The Role of Procalcitonin in Antimicrobial Stewardship Among Cancer Patients Admitted with COVID-19
por: Dagher, Hiba, et al.
Publicado: (2021)

528. Matched Retrospective Study, Comparing Molnupiravir to Nirmatrelvir-Ritonavir (Paxlovid) in the Treatment of Mild-Moderate COVID-19 in Immunocompromised Cancer Patients
por: Haddad, Andrea, et al.
Publicado: (2023)

859. The Role of Procalcitonin in Antimicrobial De-escalation and Stewardship Program in Febrile Neutropenic Cancer Patients
por: Dagher, Hiba, et al.
Publicado: (2023)

363. A Phase II Prospective Randomized Study to Assess Imipenem-Relebactam in the Management of Cancer Patients with Febrile Neutropenia
por: Chaftari, Anne-Marie, et al.
Publicado: (2023)

Real-World Use of Isavuconazole as Primary Therapy for Invasive Fungal Infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant
por: Dagher, Hiba, et al.
Publicado: (2022)

A Prospective Randomized Study Comparing Ceftolozane/Tazobactam to Standard of Care in the Management of Neutropenia and Fever in Patients With Hematological Malignancies
por: Chaftari, Anne-Marie, et al.
Publicado: (2022)

1182. The Real-World Use of Isavuconazole as Primary or salvage Therapy of Invasive Fungal infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant
por: dagher, Hiba, et al.
Publicado: (2020)

Challenge of hepatitis C in Egypt and hepatitis B in Mauritania
por: Raad, Issam I, et al.
Publicado: (2018)

Appropriate Duration of Intravenous Treatment of Candidemia and Timing of Step Down to Oral Therapy in Non-neutropenic Patients
por: Dib, Rita Wilson, et al.
Publicado: (2018)

2100. Nitroglycerin-Citrate-Ethanol Catheter Lock Solution Is Highly Effective in Eradicating Candida auris Biofilms
por: Rosenblatt, Joel, et al.
Publicado: (2018)

1257. A phase II Prospective Randomized Study to Assess Ceftolozane-Tazobactam in the Management of Febrile Neutropenia in Patients with Hematological Malignancies
por: Chaftari, Anne-Marie, et al.
Publicado: (2020)

Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia
por: Haddad, Hanine El, et al.
Publicado: (2018)

Author Correction: Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia
por: El Haddad, Hanine, et al.
Publicado: (2018)

Central Venous Catheter–associated Nocardia Bacteremia in Cancer Patients
por: Al Akhrass, Fadi, et al.
Publicado: (2011)

542. Use of Bamlanivimab in Cancer Patients with Mild-to-Moderate COVID-19
por: Brock, Patricia, et al.
Publicado: (2021)

The use of minocycline-rifampin coated central venous catheters for exchange of catheters in the setting of staphylococcus aureus central line associated bloodstream infections
por: Chaftari, Anne-Marie, et al.
Publicado: (2014)

Caprylic and Polygalacturonic Acid Combinations for Eradication of Microbial Organisms Embedded in Biofilm
por: Rosenblatt, Joel, et al.
Publicado: (2017)

Foley Catheter with Peri-Urethral Antimicrobial Irrigation for the Prevention of Catheter Associated Urinary Tract Infections – Assessment in an In Vitro Model
por: Rosenblatt, Joel, et al.
Publicado: (2017)

Comparing Diagnostic-Driven Approaches to Empiric Therapy in the Treatment of Invasive Aspergillosis in Patients with Hematologic Malignancy
por: Dib, Rita Wilson, et al.
Publicado: (2017)

1709 Mycobacterium Arupense in Cancer Patients: A Commensal Organism or a Pathogen?
por: Jordan, Mary, et al.
Publicado: (2014)

Treating invasive aspergillosis in patients with hematologic malignancy: diagnostic-driven approach versus empiric therapies
por: Dib, Rita Wilson, et al.
Publicado: (2018)

2099. Catheter-related Staphylococcus aureus Bacteremia and Septic Thrombosis: The Role of Anticoagulation and Duration of Intravenous Antibiotic Therapy
por: Dib, Rita Wilson, et al.
Publicado: (2018)

Pilot Ex Vivo and In Vitro Evaluation of a Novel Foley Catheter with Antimicrobial Periurethral Irrigation for Prevention of Extraluminal Biofilm Colonization Leading to Catheter-Associated Urinary Tract Infections (CAUTIs)
por: Vargas-Cruz, Nylev, et al.
Publicado: (2019)

Prognostic Value of Procalcitonin, C-Reactive Protein, and Lactate Levels in Emergency Evaluation of Cancer Patients with Suspected Infection
por: Chaftari, Patrick, et al.
Publicado: (2021)

Comparative Efficacies of Antimicrobial Catheter Lock Solutions for Fungal Biofilm Eradication in an in Vitro Model of Catheter-Related Fungemia
por: Rosenblatt, Joel, et al.
Publicado: (2017)

Catheter-related Complications and Potential Risk Factors Among Catheterized Cancer Patients Receiving Parenteral Nutrition at The University of Texas MD Anderson Cancer Center: A 26,000 Parenteral Nutrition-day Experience
por: Reitzel, Ruth, et al.
Publicado: (2017)

Catheter-Related Staphylococcus aureus Bacteremia and Septic Thrombosis: The Role of Anticoagulation Therapy and Duration of Intravenous Antibiotic Therapy
por: Wilson Dib, Rita, et al.
Publicado: (2018)

1171. Impact of Catheter Management on the Clinical Outcome in Adult Cancer Patients with Gram-Negative Bacteremia
por: Fares, Johny, et al.
Publicado: (2019)

Impact of Catheter Management on Clinical Outcome in Adult Cancer Patients With Gram-Negative Bacteremia
por: Fares, Johny, et al.
Publicado: (2019)

Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time period
por: Dagher, Hiba, et al.
Publicado: (2023)

Unnecessary Removal of Central Venous Catheters in Cancer Patients with Bloodstream Infections: Impact on Symptom Burden
por: Chaftari, Anne-Marie, et al.
Publicado: (2017)

2453. Repeated Exposures to Minocycline/Rifampin and + Chlorhexidine Combination Used to Coat Catheters Fails to Induce Antimicrobial Resistance
por: Vargas-Cruz, Nylev, et al.
Publicado: (2018)

1488. Invasive Pulmonary Aspergillosis in Patients with Solid Tumors: Risk Factors and Predictors of Clinical Outcomes
por: Dandachi, Dima, et al.
Publicado: (2018)

293. Lung Cancer and Hematologic Malignancy ( HM) Patients Are Associated with the Highest Risk of Progressing to Severe Disease and Mortality in Cancer Patients with COVID-19
por: Chaftari, Anne-Marie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5qf8114o9nkjorn9pn7pa3a4ig